Skip to main content
Equibles
MRVI logo

MRVI · Maravai Lifesciences Holdings, Inc. · Metrics

Track MRVI — free

Use MRVI with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$7.00 -0.20 (-2.71%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.90B
Shares
259.67M

MRVI metrics

74 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$7.19
Market cap
$1.90B

Price action

20 metrics
Price change (1W)
-4.7%
Price change (30D)
+20.6%
Price change (3M)
+45.8%
Price change (6M)
+106.2%
Price change (YTD)
+125.2%
Price change (1Y)
+210.2%
Trailing year
Price change (5Y)
-87.5%
52-week high
$9.00
52-week low
$2.36
Change from 52-week high
-18.7%
Change from 52-week low
+210.2%
Annualized volatility
68.8%
Annualized volatility (3M)
76.1%
Beta
1.3
RSI (14D)
51.7
Price vs SMA 50
+7.9%
Price vs SMA 200
+62.5%
Avg volume (3M)
3.47M
Relative volume
0.5
Average dollar volume
$23.55M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
259.67M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
9.5×
reciprocal yield 10.6%
EV / EBITDA
—
EV / EBIT
—
P / sales
9.1×
reciprocal yield 11.0%
P / book
9.3
reciprocal yield 10.8%
FCF yield
-1.9%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-4.1%

Historical valuation

8 metrics
P / E historical average (3Y)
15.9×
reciprocal yield 6.3%
P / E historical average (5Y)
15.9×
reciprocal yield 6.3%
EV / revenue historical average (3Y)
5.1×
reciprocal yield 19.4%
EV / revenue historical average (5Y)
5.7×
reciprocal yield 17.5%
EV / EBIT historical average (3Y)
10.9×
reciprocal yield 9.2%
EV / EBIT historical average (5Y)
10.9×
reciprocal yield 9.2%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
34.9%
Operating margin
-56.1%
Trailing 12 months
Net margin
-37.1%
Gross profit (TTM)
$72.85M
Operating profit (TTM)
−$117.07M
Net income (TTM)
−$77.39M
Trailing 12 months
Diluted EPS (TTM)
$-0.52
FCF margin
-17.2%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+8.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$208.78M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.6%
Year over year · more shares
Revenue CAGR (3Y)
-40.5%
Revenue CAGR (5Y)
-8.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-37.8%
Return on assets
-12.8%
Debt / equity
0.7
Current ratio
4.1
EBITDA (TTM)
—
Free cash flow (TTM)
−$35.84M
Quick ratio
3.0
Interest coverage
-4.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$77.01M
Latest balance sheet
Cash & equivalents
$70.09M
Total assets
$603.75M
Total debt
$147.10M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$25.26M
Capital expenditures (TTM)
$10.58M
R&D (TTM)
$15.22M
SG&A (TTM)
$128.00M
Stock compensation (TTM)
$29.93M
R&D / revenue
7.3%
Stock compensation / revenue
14.3%

Ownership (13F)

3 metrics
13F filers
178
13F filer change QoQ
+19
Institutional ownership
54.2%

Short interest

3 metrics
Short interest
3.6%
Latest settlement · 4.6 days to cover
Days to cover
4.6d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1823239 CUSIP 56600D107 13F (30d) 128 filings 128 filers Visit website Investor relations